BUTISOL SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Butisol Sodium patents expire, and when can generic versions of Butisol Sodium launch?
Butisol Sodium is a drug marketed by Meda Pharms and Mylan Speciality Lp and is included in two NDAs.
The generic ingredient in BUTISOL SODIUM is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
Summary for BUTISOL SODIUM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 10 |
| Patent Applications: | 296 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | BUTISOL SODIUM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BUTISOL SODIUM
US Patents and Regulatory Information for BUTISOL SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meda Pharms | BUTISOL SODIUM | butabarbital sodium | ELIXIR;ORAL | 085380-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Speciality Lp | BUTISOL SODIUM | butabarbital sodium | TABLET;ORAL | 000793-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Speciality Lp | BUTISOL SODIUM | butabarbital sodium | TABLET;ORAL | 000793-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Speciality Lp | BUTISOL SODIUM | butabarbital sodium | TABLET;ORAL | 000793-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Speciality Lp | BUTISOL SODIUM | butabarbital sodium | TABLET;ORAL | 000793-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
